After it’s been rumored to be in the game earlier this month, no wonder One Medical found a new home. After a wild public offering, the value of the American consumer healthcare and technology company fell below its IPO price, making it an obvious target for a suitable buyer.
But after CVS left the table, it wasn’t a healthcare organization that bought up the former VC favorite, nor did it turn into a private equity platform. Instead, Amazon got it in a deal worth about $3.9 billion. At $18 per share, One Medical is exiting the public markets at a price higher than its IPO price, a win for the money-losing company.
But what do we do with the Amazon deal? We covered news on TechCrunchas well as TechCrunch+ did some digging into what a small company could offer to its new parent company, so we’re here to share a few more thoughts on that.
From Walter Thompson, Miranda Halpern as well as Alex Wilhelmthree views follow the Amazon-One Medial transaction.
Walter Thompson: Amazon is a black hole created by the death of Main Street retail.
One Medical’s CEO said the acquisition of his Amazon company is “an opportunity to transform healthcare and improve outcomes.” But I interpreted the pending $3.9 billion purchase as a bright flashing sign that the world’s largest retailer is not afraid of regulatory oversight or interference. Amazon has gone beyond generating revenue: at the moment, the company mainly exists to build additional mass.
Credit: techcrunch.com /